Fostering Collaboration to Accelerate Drug Discovery with the Chicago Biomedical Consortium’s (CBC) Dr. Michelle Hoffmann

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Michelle Hoffmann, PhD, Executive Director of the Chicago Biomedical Consortium (CBC). CBC is a consortium of biomedical researchers across Northwestern University, the University of Illinois at Chicago and the University of Chicago supported by the Searle Funds at The Chicago Community Trust. The CBC’s mission is to stimulate collaboration among scientists to accelerate discovery that will transform biomedical research and improve human health. At the CBC, Dr. Hoffmann is reshaping the organization to train local PhD talent in early-stage commercialization and fund high-potential biopharma innovations from Chicago’s universities. Previously, she served as Senior Vice President of Deep Tech at P33 and spent 15 years helping life sciences companies grow as a senior vice president at Back Bay Life Science Advisors, where she worked on major transactions including platform and asset deals with Gilead and AbbVie. Dr. Hoffmann has a PhD in molecular and cellular biology from the University of California Berkeley and completed a postdoctoral fellowship at Brandeis University. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured